Eisai Co., Ltd. et al v. Bionpharma Inc. > Summary
Court Case Number 1:18-cv-00618
Filing Date Apr 24, 2018
Termination Date Oct 24, 2018
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Defendant
Plaintiff Attorneys
12NOVARTIS PHARMA AG
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Bruce M. Wexler
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Young J. Park
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Simon F Kung
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Aaron Paul Selikson
Paul Hastings
NOVARTIS PHARMA AG
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
NOVARTIS PHARMA AG
Attorney Name: Bruce M. Wexler
Paul Hastings
NOVARTIS PHARMA AG
Attorney Name: Young J. Park
Paul Hastings
NOVARTIS PHARMA AG
Attorney Name: Simon F Kung
Paul Hastings
NOVARTIS PHARMA AG
Attorney Name: Aaron Paul Selikson
Paul Hastings
Defendant Attorneys
Bionpharma Inc.
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07750028 | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide | Jul 6, 2010 |
| 06740669 | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic | May 25, 2004 |
